Clinical significance of surface antigen expression in children with acute myeloid leukemia: Results of study AML-BFM-87

Blood

Volumn 86, Issue 8, 1995, Pages 3097-3108

  Creutzig, Ursula ^a   Harbott, Jochen ^b   Sperling, Christian ^b   Ritter, Jörg ^b   Zimmermann, Martin ^b   Löffler, Helmut ^b   Riehm, Hansjörg ^b   Schellong, Günther ^b   Ludwig, Wolf Dieter ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DAUNORUBICIN; ETOPOSIDE; LEUKEMIA ANTIGEN; MEMBRANE ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ANTIGEN EXPRESSION; ARTICLE; CHILD; CHROMOSOME ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD;

EID: 0028845148     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v86.8.3097.3097     Document Type: Article

References (75)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C, French-American-British (FAB) Cooperative Group: Proposals for the classification of the acute leukaemias. Br J Haematol 33:451, 1976
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 103:626, 1985
3. Neame PB, Soamboonsrup P, Browman GP, Meyer RM, Benger A, Wilson WEC, Walker IR, Saeed N, McBride JA: Classifying acute leukemia by immunophenotyping: A combined FAB-immunologic classification of AML. Blood 68:1355, 1986
4. Heim S, Mitelman F: Cytogenetic analysis in the diagnosis of acute leukemia. Cancer 70:1701, 1992
5. Knapp W: Serology of myeloid leukemias. Cancer Rev 8:66, 1987
6. Keating MJ, Smith TL, Kantarjian H, Cork A, Walters R, Trujillo JM, McCredie KB, Gehan EA, Freireich EJ: Cytogenetic pattern in acute myelogenous leukemia: A major reproducible determinant of outcome. Leukemia 2:403, 1988
7. Woods WG, Nesbit ME, Buckley J, Lampkin BC, McCreadie S, Kim TH, Piomelli S, Kersey JH, Feig S, Bernstein I, Hammond D: Correlation of chromosome abnormalities with patient characteristics, histologic subtype, and induction success in children with acute nonlymphocytic leukemia. J Clin Oncol 3:3, 1985
8. Sansone R, Negri D: Cytogenetic features of neonatal leukemias. Cancer Genet Cytogenet 63:56, 1992
9. Campana D, Coustan-Smith E, Janossy G: The immunologic detection of minimal residual disease in acute leukemia. Blood 76:163, 1990
10. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C: Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0). Br J Haematol 78:325, 1991
11. Buccheri V, Shetty V, Yoshida N, Morilla R, Matutes E, Catovsky D: The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: A comparison with light and electron microscopy cytochemistry. Br J Haematol 80:62, 1992
12. van't Veer MB: The diagnosis of acute leukemia with undifferentiated or minimally differentiated blasts. Ann Hematol 64:161, 1992
13. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med 103:460, 1985
14. Cuneo A, Michaux J-L, Ferrant A, Van Hove L, Bosly A, Stul M, Cin PD, Vandenberghe E, Cassiman J-J, Negrini M, Piva N, Castoldi G, Van den Berghe H: Correlation of cytogenetic patterns and clinicobiological features in adult acute myeloid leukemia expressing lymphoid markers. Blood 79:720, 1992
15. Paietta E, Van Ness B, Bennett J, Racevskis J, Gucalp R, Cassileth P, Wiernik PH: Lymphoid lineage-associated features in acute myeloid leukaemia: Phenotypic and genotypic correlations. Br J Haematol 82:324, 1992
16. Drexler HG, Thiel E, Ludwig WD: Acute myeloid leukemias expressing lymphoid-associated antigens: Diagnostic incidence and prognostic significance. Leukemia 7:489, 1993
17. Second MIC Cooperative Study Group: Morphologic, immunologic, and cytogenetic (MIC) working classification of the acute myeloid leukaemias. Br J Haematol 68:487, 1988
18. Kita K, Nakase K, Miwa H, Masuya M, Nishii K, Morita N, Takakura N, Otsuji A, Shirakawa S, Ueda T, Nasu K, Kyo T, Dohy H, Kamada N: Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: Frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 80:470, 1992
19. Hurwitz CA, Raimondi SC, Head D, Krance R, Mirro J Jr, Kalwinsky DK, Ayers GD, Behm FG: Distinctive immunophenotypic features of t(8;21)(q22;q22) in acute myeloblastic leukemia in children. Blood 80:3182, 1992
20. Kita K, Miwa H, Nakase K, Kawakami K, Kobayashi T, Shirakawa S, Tanaka I, Ohta C, Tsutani H, Oguma S, Kyo T, Dohy H, Kamada N, Nasu K, Uchino H, (The Japan Cooperative Group of Leukemia/Lymphoma): Clinical importance of CD7 expression in acute myelocytic leukemia. Blood 81:2399, 1993
21. Reading CL, Estey EH, Huh YO, Claxton DJ, Sanchez G, Terstappen LWMM, O'Brien MC, Baron S, Deisseroth AB: Expression of unusual immunophenotype combinations in acute myelogenous leukemia. Blood 81:3083, 1993
22. Claxton DF, Reading CL, Nagarajan L, Tsujimoto Y, Andersson BS, Estey E, Cork A, Huh YO, Trujillo J, Deisseroth AB: Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia. Blood 80:582, 1992
23. Rovelli A, Biondi A, Cantu Rajnoldi A, Conter V, Giudici G, Jankovic M, Locasciulli A, Rizzari C, Romitti L, Rossi MR, Schirò R, Tosi S, Uderzo C, Masera G: Microgranular variant of acute promyelocytic leukemia in children. J Clin Oncol 10:1413, 1992
24. Adriaansen HJ, te Boekhorst PAW, Hagemeijer AM, van der Schoot CE, Delwel HR, van Dongen JJM: Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression. Blood 81:3043, 1993
25. Borowitz MJ, Gockerman JP, Moore JO, Civin CI, Page SO, Robertson J, Bigner SH: Clinicopathologic and cytogenetic features of CD34 (My 10)-positive acute nonlymphocytic leukemia. Am J Clin Pathol 91:265, 1989
26. Geller R, Zahurak M, Hurwitz CA, Burke PJ, Karp JE, Piantadosi S, Civin CI: Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stemcell glycoprotein CD34 (My10). Br J Haematol 76:340, 1990
27. Sperling C, Büchner T, Creutzig U, Ritter J, Harbott J, Fonatsch C, Sauerland C, Mielcarek M, Maschmeyer G, Löffler H, Ludwig WD: Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood and adult de novo AML. Leuk Lymphoma 17:417, 1995
28. Swirsky DM, Greaves MF, Gray RG, Rees JK: Terminal deoxynucleotidyl transferase and HLA-DR expression appear unrelated to prognosis of acute myeloid leukaemia. Br J Haematol 70:193, 1988
29. Lee EJ, Pollak A, Leavitt RD: Minimally differentiated acute nonlymphocytic leukemia: A distinct entity. Blood 70:1400, 1987
30. Creutzig U, Ritter J, Schellong G: Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in the study AML-BFM-83 as compared with study AML-BFM-78. Blood 75:1932, 1990
31. Marosi C, Köller U, Koller-Weber E, Schwarzinger I, Schneider B, Jäger U, Vahls P, Nowotny H, Pirc-Danoewinata H, Steger G, Kreiner G, Wagner B, Lechner K, Lutz D, Bettelheim P, Haas OA: Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML. Cancer Genet Cytogenet 61:14, 1992
32. Pui CH, Behm FG, Crist WM: Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 82:343, 1993
33. Ludwig WD, Raghavachar A, Thiel E: Immunophenotypic classification of acute lymphoblastic leukaemia, in Hoelzer D (ed): Bailliere's Clinical Haematology. London, UK, Bailliere Tindall, 1994, p 235
34. Smith FO, Lampkin BC, Versteeg C, Flowers DA, Dinndorf PA, Buckley JD, Woods WG, Hammond GD, Bernstein ID: Expression of lymphoid-associated cell surface antigens by childhood acute myeloid leukemia cells lacks prognostic significance. Blood 79:2415, 1992
35. Kuerbitz SJ, Civin CI, Krischer JP, Ravindranath Y, Steuber CP, Weinstein HJ, Winick N, Ragab AH, Gresik MV, Crist WM: Expression of myeloid-associated and lymphoid-associated cell surface antigens in acute myeloid leukemia of childhood: A Pediatric Oncology Group Study. J Clin Oncol 10:1419, 1992
36. Sperling C, Büchner T, Sauerland C, Fonatsch C, Thiel E, Ludwig WD: CD34 expression in de novo acute myeloid leukaemia. Br J Haematol 85:635, 1993
37. Jensen AW, Hokland M, Jorgensen H, Justesen J, Ellegaard J, Hokland P: Solitary expression of CD7 among T-cell antigens in acute myeloid leukemia: Identification of a group of patients with similar T-cell receptor beta and delta rearrangements and course of disease suggestive of poor prognosis. Blood 78:1292, 1991
38. Urbano-Ispizua A, Matutes E, Villamor N, Sierra J, Pujades A, Reverter JC, Feliu E, Cervantes F, Vives-Corrons JL, Montserrat E, Rozman C: The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia. Br J Haematol 81:178, 1992
39. Del Poeta G, Stasi R, Venditti A, Suppo G, Aronica G, Bruno A, Masi M, Tabilio A, Papa G: Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Leukemia 8:388, 1994
40. Bradstock K, Matthews J, Benson E, Page F, Bishop J, and the Australian Leukaemia Study Group: Prognostic value of immunophenotyping in acute myeloid leukemia. Blood 84:1220, 1994
41. Griffin JD, Davis R, Nelson DA, Davey FR, Mayer RJ, Schiffer C, McIntrye OR, Bloomfield CD: Use of surface marker analysis to predict outcome of adult myeloblastic leukemia. Blood 68:1232, 1986
42. Schwarzinger I, Valent P, Köller U, Marosi C, Schneider B, Haas O, Knapp W, Lechner K, Bettelheim P: Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia. J Clin Oncol 8:423, 1990
43. - phenotypes with shorter survival. Leukemia 6:393, 1992
44. San Miguel JF, Ojeda E, Gonzalez M, Orfao A, Canizo MC, Sanchez J, Lopez Borrasca A: Prognostic value of immunological markers in acute myeloblastic leukemia. Leukemia 3:108, 1989
45. Lee EJ, Yang J, Leavitt RD, Testa JR, Civin CI, Forrest A, Schiffer CA: The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia. Leukemia 6:1203, 1992
46. Lo Coco F, De Rossi G, Pasqualetti D, Lopez M, Diverio D, Latagliata R, Fenu S, Mandelli F: CD7 positive acute myeloid leukaemia: A subtype associated with cell immaturity. Br J Haematol 73:480, 1989
47. Sperling C, Seibt-Jung H, Gassmann W, Komischke B, Sauerland C, Hiddemann W, Löffler H, Büchner T, Thiel E, Ludwig WD: Immunophenotype of acute myeloid leukemia: Correlation with morphological characteristics and therapy response. Recent Results Cancer Res 131:381, 1993
48. Holowiecki J, Lutz D, Krzemien S, Stella Holowiecka B, Graf F, Kelenyi G, Schranz V, Callea V, Brugiatelli M, Neri A, Magyarlaki T, Ihle R, Jagoda K, Rudzka E: CD-15 antigen detected by the VIM-D5 monoclonal antibody for prediction of ability to achieve complete remission in acute nonlymphocytic leukemia. Acta Haematol 76:16, 1986
49. Campos J, Guyotat D, Archimbaud E, Devaux Y, Treille D, Larese A, Maupas J, Gentilhomme O, Ehrsam A, Fière D: Surface marker expression in adult acute myeloid leukaemia, correlations with initial characteristics, morphology and response to therapy. Br J Haematol 72:161, 1989
50. Ball ED, Davis RB, Griffin JD, Mayer RJ, Davey FR, Arthur DC, Wurster-Hill D, Noll W, Elghetany MT, Allen SL, Rai K, Lee EJ, Schiffer CA, Bloomfield CD: Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood 77:2242, 1991
51. Cross AH, Goorha RM, Nuss R, Behm FG, Murphy SB, Kalwinsky DK, Raimondi S, Kitchingman GR, Mirro J: Acute myeloid leukemia with T-lymphoid features: A distinct biological and clinical entity. Blood 72:579, 1988
52. Ciolli S, Leoni F, Caporale R, Pascarella A, Salti F, Rossi-Ferrini P: CD34 expression fails to predict the outcome in adult acute myeloid leukemia. Haematologica 78:151, 1993
53. Gucalp R, Paietta E, Weinberg V, Papenhausen P, Dutcher JP, Wiernik PH: Terminal transferase expression in acute myeloid leukaemia: Biology and prognosis. Br J Haematol 78:48, 1991
54. Creutzig U, Ritter J, Zimmermann M, Schellong G, for the AML-BFM Study Group: Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia (AML): Unexpected results of the childhood AML Study BFM-87. J Clin Oncol 11:279, 1993
55. Ludwig WD, Bartram CR, Ritter J, Raghavachar A, Hiddemann W, Heil G, Harbott J, Seibt-Jung H, Teichmann JV, Riehm H: Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis. Blood 71:1518, 1988
56. Third International Workshop on Chromosomes in Leukemia 1980: Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia. Cancer Genet Cytogenet 4:111, 1981
57. ISCN: An international system for human cytogenetic nomenclature, in Harnden DG, Klinger HP (eds): ISCN 1985. Basel, Switzerland, Karger, 1985
58. ISCN: Guidelines for cancer cytogenetics, supplement to an international system for human cytogenetic nomenclature, in Mitelman F (ed): ISCN 1991. Basel, Switzerland, Karger, 1991
59. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Statist Assoc 53:457, 1958
60. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
61. Sox HCJ: Probability theory in the use of diagnostic tests. Ann Intern Med 104:60, 1986
62. Wineman JP, Gilmore GL, Gritzmacher C, Torbett BE, Müller-Sieburg CE: CD4 is expressed on murine pluripotent hematopoietic stem cells. Blood 80:1717, 1992
63. Stewart SJ, Fujimoto J, Levy R: Human T lymphocytes and monocytes bear the same Leu-3 (T4) antigen. J Immunol 136:3773, 1986
64. Chabannon C, Wood P, Torok Storb B: Expression of CD7 on normal human myeloid progenitors. J Immunol 149:2110, 1992
65. Schmidt CA, Oettle H, Neubauer A, Seeger K, Thiel E, Huhn D, Siegert W, Ludwig WD: Rearrangements of T-cell receptor delta, gamma and beta genes in acute myeloid leukemia coexpressing T-lymphoid features. Leukemia 6:1263, 1992
66. Vinante F, Pizzolo G, Rigo A, Vincenzi C, Sorio C, Cassatella M, Berton G: The CD4 molecule belongs to the phenotypic repertoire of most cases of acute myeloid leukemia. Leukemia 6:1257, 1992
67. Stasi R, Del Poeta G, Venditti A, Masi M, Stipa E, Dentamaro T, Cox C, Dallapiccola B, Papa G: Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0). Blood 83:1619, 1994
68. Pui CH, Behm FG, Kalwinsky DK, Murphy SB, Butler DL, Dahl GV, Mirro J: Clinical significance of low levels of myeloperoxidase positivity in childhood acute nonlymphoblastic leukemia. Blood 70:51, 1987
69. Mitelman F, Heim S: Quantitative acute leukemia cytogenetics. Genes Chromosom Cancer 5:57, 1992
70. De Rossi G, Avvisati G, Coluzzi S, Fenu S, LoCoco F, Lopez M, Nanni M, Pasqualetti D, Mandelli F: Immunological definition of acute promyelocytic leukemia (FAB M3): A study of 39 cases. Eur Haematol 45:168, 1990
71. Paietta E, Andersen J, Gallagher R, Bennett J, Yunis J, Cassileth P, Rowe J, Wiernik PH: The immunophenotype of acute promyelocytic leukemia (APL): an ECOG Study. Leukemia 8:1108, 1994
72. Pui CH, Raimondi SC, Head DR, Schell MJ, Rivera GK, Mirro J Jr, Crist WM, Behm FG: Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse. Blood 78:1327, 1991
73. Köller U, Haas OA, Ludwig WD, Bartram CR, Harbott J, Panzer-Grümayer R, Hansen-Hagge TE, Ritter J, Creutzig U, Knapp W, Gadner H: Phenotypic and genotypic heterogeneity in infant acute leukemia II. Acute non-lymphoblastic leukemia. Leukemia 3:708, 1989
74. Selleri C, Notaro R, Catalano L, Fontana R, Del Vecchio L, Rotoli B: Prognostic irrelevance of CD34 in acute myeloid leukaemia. Br J Haematol 82:479, 1992
75. Machnicki JL, Bloomfield CD: Clinical significance of the cytogenetics of acute leukemias. Oncol 4:23, 1990